Julia Mae Beasley Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 4140 Crossings Ct Ste 101-103, Prince George, VA 23875 Phone: 833-510-4357 Fax: 866-460-2997 |
Mr. James William La Prade, LPC, LMFT Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 6610 Commons Dr, Prince George, VA 23875 Phone: 804-861-0393 Fax: 804-863-1287 |
Elizabeth Dillard, M.A. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 4140 Crossings Ct Ste 101-103, Prince George, VA 23875 Phone: 804-408-4806 |
Natasha Gonzalez, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 7020 Birchett Dr, Prince George, VA 23875 Phone: 804-514-5290 |
Ruthe Laurore, LPC, NCC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 4701 Owens Way Ste 200, Prince George, VA 23875 Phone: 804-458-5500 Fax: 804-458-5501 |
Alfreda Best, CSAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 4140 Crossings Ct Ste 101-103, Prince George, VA 23875 Phone: 833-510-4357 |
Dale Marie Chatman, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 7305 John Elizabeth Pl, Prince George, VA 23875 Phone: 804-926-7675 |
Scott Thomas Gilchrist, LCSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 4411 Crossings Blvd, Prince George, VA 23875 Phone: 804-691-7917 |
News Archive
Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Nile's post-acute development program for cenderitide, which has the goal of reducing cardiovascular mortality and cardiovascular re-hospitalization in the post-acute period in patients with acute decompensated heart failure.
athenahealth, Inc., a leading provider of web-based practice management, electronic health record, and patient communication services to medical groups, today announced that the latest version of its web-based EHR service, athenaClinicalsSM Version 10.6, has been inspected by the Certification Commission for Health Information Technology (CCHIT®) and is certified EHR technology, IFR Stage 1, preliminarily meeting 24 of 24 requirements for Eligible Providers published by the U.S. Department of Health and Human Services (HHS) in the Interim Final Rule.
Resverlogix Corp. is pleased to announce that dosing in SUSTAIN, a Phase 2b clinical trial to assess lipid trends and safety of RVX-208, has been completed on schedule.
As the Wall Street Journal reports that one of the biggest issues right now is making sure these newly insured people have insurance cards, other news outlets detail reports and questions about the number of enrollees.
› Verified 7 days ago